Detailed pdf on Thiopentone sodium - group, chemical structure, formulation, dilution, available forms in market, routes of administration, dosage, mechanism of action, pharmacokinetics, pharmacodynamics, indications, contraindications, adverse effects and special points . PDF preferences - - ASCII only - CO2, N2O, O2, H2O, Ca(OH)2, Na2CO3 all written as plain text - no Unicode subscripts, no dark squares anywhere - Suitable spacing - Proper gaps between sections so that easy to distinguish between sections and easy to read ; sections on the same page where possible - All table cells use Paragraph objects - text wraps automatically inside cells, rows grow to fit content, no text overflows borders - Column widths tuned per table - each table has appropriate widths for its content type - No overlapping or compressed text - adjust column widths to stay readable - Font - Liberation Sans - Give me coloured headings and highlight the doses or cautions or important points in different colors which are pleasant to see and always use subtle colors in the pdf but it shouldn’t be overwhelming. Please keep changing the colour palette themes used for PDFs from one pdf to another pdfs automatically with clear distinct colours for headings and subheadings and it should not be overwhelming but pleasant to look and read. Please use important sentences or pearls in dark coloured. Also include flowcharts or tables if needed. - dark colored text to be 100% blacker and other colours be the same 100%. - Font size 10.5 pt - Body line spacing 15.5 pt - Cell line spacing 13 pt - Coloured labels - 100% saturated - Headings should be dark coloured according to the colour palette highlighted with suitable pleasant colour.
mkdir -p /home/daytona/workspace/thiopentone-pdf && cat > /home/daytona/workspac…
cd /home/daytona/workspace/thiopentone-pdf && python build.py 2>&1
ls -lh /home/daytona/workspace/thiopentone-pdf/Thiopentone_Sodium_Reference.pdf
Thiopentone Sodium Reference
PDF Document · PDF
| # | Section | Key Highlights |
|---|---|---|
| 1 | Drug Group & Classification | Thiobarbiturate; Schedule III controlled substance; ultra-short acting |
| 2 | Chemical Structure | IUPAC name, molecular formula C11H17N2NaO2S, pKa 7.45, pH 10.5-11, protein binding 80-86% |
| 3 | Formulation & Dilution | Na2CO3 6% w/w addition; standard 2.5% solution; incompatible diluents listed; stability data |
| 4 | Market Forms | Pentothal, Intraval Sodium, Nesdonal, Ravonal, Tiopental with regions and vial sizes |
| 5 | Routes of Administration | IV primary; rectal in children; intraarterial injection emergency management table |
| 6 | Dosage | Complete table by patient group (adult, elderly, obese, paediatric, neonate, shocked); ECT, status epilepticus, ICP doses |
| 7 | Mechanism of Action | GABA-A allosteric modulation, chloride channel prolongation, direct GABA-mimetic at high dose; step-by-step flowchart |
| 8 | Pharmacokinetics | 3-compartment model; full PK table; redistribution phases alpha/beta/gamma; factors altering PK |
| 9 | Pharmacodynamics | CNS, CVS, Respiratory, and other system effects - separate tables for each |
| 10 | Indications | 9 indications with details |
| 11 | Contraindications | Absolute (porphyria highlighted in red) and relative CIs |
| 12 | Adverse Effects | 17-row comprehensive adverse effects table |
| 13 | Special Points | Incompatibility quick-reference table; thiopentone vs. propofol comparison; 8 clinical situations; 5 clinical pearls; storage table |